🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 12

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 12 of 20
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Jan 9, 2025 at 3:22 PM#56
DanielChem_CHI said:
Say what you would expect to see if you were wrong, before you look.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

Last edited: Jan 9, 2025 at 4:22 PM
26 24julia.endo, JessicaM_2024, TomFromTexas and 23 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Jan 17, 2025 at 9:59 PM#57
DanielChem_CHI said:
Say what you would expect to see if you were wrong, before you look.

Genuinely useful, thank you. I had the facts and not the framework.

Last edited: Jan 17, 2025 at 11:59 PM
27 0Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 24 others
Reply Quote Save Share Report
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Jan 26, 2025 at 4:31 AM#58

Adding the clinical framing, because it changes how the question reads. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

28 1laura_annarbor, JenMemphis, pat_auckland and 25 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Feb 3, 2025 at 10:59 AM#59
Dr.NutriCornell said:
Worth answering the question that was asked rather than the one behind it.

Can confirm. Same sequence, different timescale.

29 2alex_tucson, kevin_tulsa, Dr.PainCLE and 26 others
Reply Quote Save Share Report
matt_MKE
Member
312
1,345
Sep 2024
Milwaukee, WI
Feb 11, 2025 at 5:22 PM#60
Dr.NutriCornell said:
Worth answering the question that was asked rather than the one behind it.

Adding the part of the answer the thread has not reached. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Last edited: Feb 11, 2025 at 8:22 PM
1 24DanielChem_CHI
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register